$0.98
+0.1
(+11.1%)▲
Market Capitalization | $152.9M |
Revenue TTM | $20.1M |
EBITDA | $2.6M |
Earnings Per Share (EPS) | $0.02 |
PE Ratio | 48.83 |
Profit Margin | 14.44% |
Quarterly Earnings Growth YOY | -0.12% |
Return On Equity TTM | 11.33% |
15.31%
Downside
Day's Volatility :16.98%
Upside
1.98%
42.86%
Downside
52 Weeks Volatility :97.8%
Upside
96.16%
Period | Jin Medical International Ltd | Index (Russel 2000) |
---|---|---|
3 Months | -64.23% | 0.0% |
6 Months | -68.19% | 0.0% |
1 Year | -17.41% | 0.0% |
3 Years | 145.69% | -21.1% |
Insights on Jin Medical International Ltd
Revenue is down for the last 2 quarters, 9.56M → 5.27M (in $), with an average decrease of 44.8% per quarter
Netprofit is down for the last 2 quarters, 1.11M → 897.04K (in $), with an average decrease of 19.3% per quarter
In the last 1 year, Intuitive Surgical, Inc. has given 73.3% return, outperforming this stock by 90.7%
FY19 | Y/Y Change | |
---|---|---|
Revenue | 20.4M | - |
Net Income | 3.6M | - |
Net Profit Margin | 17.91% | - |
FY20 | Y/Y Change | |
---|---|---|
Revenue | 16.2M | ↓ 20.49% |
Net Income | 2.2M | ↓ 39.52% |
Net Profit Margin | 13.62% | ↓ 4.29% |
FY21 | Y/Y Change | |
---|---|---|
Revenue | 20.8M | ↑ 28.22% |
Net Income | 2.6M | ↑ 19.3% |
Net Profit Margin | 12.67% | ↓ 0.95% |
FY22 | Y/Y Change | |
---|---|---|
Revenue | 19.2M | ↓ 7.58% |
Net Income | 2.7M | ↑ 2.84% |
Net Profit Margin | 14.1% | ↑ 1.43% |
FY23 | Y/Y Change | |
---|---|---|
Revenue | 19.8M | ↑ 3.29% |
Net Income | 2.9M | ↑ 6.34% |
Net Profit Margin | 14.52% | ↑ 0.42% |
FY24 | Y/Y Change | |
---|---|---|
Revenue | 19.8M | ↑ 0.0% |
Net Income | 2.9M | ↑ 0.0% |
Net Profit Margin | 14.52% | ↑ 0.0% |
Q3 FY22 | Q/Q Change | |
---|---|---|
Revenue | 4.9M | ↑ 0.0% |
Net Income | 740.3K | ↑ 0.0% |
Net Profit Margin | 15.23% | ↑ 0.0% |
Q4 FY22 | Q/Q Change | |
---|---|---|
Revenue | 5.1M | ↑ 5.45% |
Net Income | 883.2K | ↑ 19.29% |
Net Profit Margin | 17.23% | ↑ 2.0% |
Q2 FY23 | Q/Q Change | |
---|---|---|
Revenue | 4.8M | - |
Net Income | 555.9K | - |
Net Profit Margin | 11.62% | - |
Q1 FY24 | Q/Q Change | |
---|---|---|
Revenue | 9.6M | ↑ 100.0% |
Net Income | 1.1M | ↑ 100.0% |
Net Profit Margin | 11.62% | ↑ 0.0% |
Q2 FY24 | Q/Q Change | |
---|---|---|
Revenue | 5.3M | ↓ 44.83% |
Net Income | 897.0K | ↓ 19.32% |
Net Profit Margin | 16.99% | ↑ 5.37% |
FY19 | Y/Y Change | |
---|---|---|
Total Assets | 20.4M | - |
Total Liabilities | 9.7M | - |
FY20 | Y/Y Change | |
---|---|---|
Total Assets | 20.8M | ↑ 2.23% |
Total Liabilities | 10.0M | ↑ 3.69% |
FY21 | Y/Y Change | |
---|---|---|
Total Assets | 21.9M | ↑ 5.22% |
Total Liabilities | 7.9M | ↓ 21.38% |
FY22 | Y/Y Change | |
---|---|---|
Total Assets | 20.9M | ↓ 4.39% |
Total Liabilities | 5.7M | ↓ 27.54% |
FY23 | Y/Y Change | |
---|---|---|
Total Assets | 32.9M | ↑ 57.14% |
Total Liabilities | 8.9M | ↑ 56.46% |
FY24 | Y/Y Change | |
---|---|---|
Total Assets | 32.9M | ↑ 0.0% |
Total Liabilities | 8.9M | ↑ 0.0% |
Q4 FY22 | Q/Q Change | |
---|---|---|
Total Assets | 31.0M | ↑ 48.15% |
Total Liabilities | 7.5M | ↑ 31.07% |
Q1 FY23 | Q/Q Change | |
---|---|---|
Total Assets | 31.0M | ↑ 0.0% |
Total Liabilities | 7.5M | ↑ 0.0% |
Q2 FY23 | Q/Q Change | |
---|---|---|
Total Assets | 32.9M | ↑ 6.06% |
Total Liabilities | 8.9M | ↑ 19.37% |
Q3 FY23 | Q/Q Change | |
---|---|---|
Total Assets | 32.9M | ↑ 0.0% |
Total Liabilities | 8.9M | ↑ 0.0% |
Q1 FY24 | Q/Q Change | |
---|---|---|
Total Assets | 32.9M | ↑ 0.0% |
Total Liabilities | 8.9M | ↑ 0.0% |
Q2 FY24 | Q/Q Change | |
---|---|---|
Total Assets | 41.2M | ↑ 25.09% |
Total Liabilities | 15.0M | ↑ 68.14% |
FY19 | Y/Y Change | |
---|---|---|
Operating Cash Flow | -1.3M | - |
Investing Cash Flow | 126.9K | - |
Financing Cash Flow | 2.4M | - |
FY20 | Y/Y Change | |
---|---|---|
Operating Cash Flow | 2.5M | ↓ 288.85% |
Investing Cash Flow | -2.0M | ↓ 1642.9% |
Financing Cash Flow | -343.9K | ↓ 114.56% |
FY21 | Y/Y Change | |
---|---|---|
Operating Cash Flow | 5.8M | ↑ 133.43% |
Investing Cash Flow | -1.1M | ↓ 45.49% |
Financing Cash Flow | -2.9M | ↑ 734.59% |
FY22 | Y/Y Change | |
---|---|---|
Operating Cash Flow | 1.6M | ↓ 72.95% |
Investing Cash Flow | -120.9K | ↓ 88.68% |
Financing Cash Flow | 121.9K | ↓ 104.25% |
Q3 FY22 | Q/Q Change | |
---|---|---|
Operating Cash Flow | 816.0K | ↑ 0.0% |
Investing Cash Flow | -40.0K | ↑ 0.0% |
Financing Cash Flow | 64.2K | ↑ 0.0% |
Q4 FY22 | Q/Q Change | |
---|---|---|
Operating Cash Flow | 1.4M | ↑ 68.11% |
Investing Cash Flow | -3.5M | ↑ 8732.57% |
Financing Cash Flow | 4.0M | ↑ 6212.06% |
Q1 FY23 | Q/Q Change | |
---|---|---|
Operating Cash Flow | 1.4M | ↑ 0.0% |
Investing Cash Flow | -3.5M | ↑ 0.0% |
Financing Cash Flow | 4.0M | ↑ 0.0% |
Sell
Neutral
Buy
Jin Medical International Ltd is currently in a favorable trading position ( BUY ) according to technical analysis indicators.
Company Name | 1 Month | 6 Month | 1 Year | 3 Years | 5 Years |
---|---|---|---|---|---|
Jin Medical International Ltd | -52.59% | -68.19% | -17.41% | 145.69% | 145.69% |
Intuitive Surgical, Inc. | 4.31% | 35.18% | 73.3% | 60.89% | 172.5% |
Resmed Inc. | 2.02% | 21.06% | 56.96% | -2.95% | 66.66% |
Becton, Dickinson And Company | -6.54% | -1.37% | -5.82% | -8.88% | -14.13% |
West Pharmaceutical Services Inc | 1.54% | 0.15% | -7.34% | -27.73% | 119.9% |
Alcon Ag | -6.64% | 0.98% | 18.18% | 12.41% | 59.58% |
Company Name | P/E Ratio | P/B Ratio | PEG Ratio | EPS | ROE | ROA | Div Yield | BVPS |
---|---|---|---|---|---|---|---|---|
Jin Medical International Ltd | 48.83 | 48.83 | NA | 0.0 | 0.11 | 0.04 | NA | 0.17 |
Intuitive Surgical, Inc. | 87.0 | 87.0 | 4.02 | 6.84 | 0.16 | 0.08 | NA | 43.75 |
Resmed Inc. | 33.11 | 33.11 | 1.9 | 7.71 | 0.24 | 0.13 | 0.01 | 35.39 |
Becton, Dickinson And Company | 37.88 | 37.88 | 1.03 | 13.11 | 0.06 | 0.03 | 0.02 | 89.5 |
West Pharmaceutical Services Inc | 48.04 | 48.04 | 5.96 | 6.66 | 0.18 | 0.1 | 0.0 | 37.96 |
Alcon Ag | 37.71 | 37.71 | 3.21 | 3.03 | 0.06 | 0.03 | 0.0 | 43.25 |
Company Name | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin |
---|---|---|---|---|---|
Jin Medical International Ltd | NA | $152.9M | 145.69% | 48.83 | 14.44% |
Intuitive Surgical, Inc. | Buy | $191.8B | 172.5% | 87.0 | 28.51% |
Resmed Inc. | Buy | $36.6B | 66.66% | 33.11 | 23.15% |
Becton, Dickinson And Company | Buy | $64.2B | -14.13% | 37.88 | 7.13% |
West Pharmaceutical Services Inc | Buy | $23.4B | 119.9% | 48.04 | 17.37% |
Alcon Ag | Buy | $43.6B | 59.58% | 37.71 | 11.89% |
Organization | Jin Medical International Ltd |
Employees | 245 |
CEO | Mr. Erqi Wang |
Industry | Miscellaneous |